The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Fetuin-A and Incident Diabetes Mellitus in Older Persons
Open accessAbstract
CONTEXT: Fetuin-A is a hepatic secretory protein that binds the insulin receptor and inhibits insulin action in vitro. In prior cross-sectional studies in humans, higher fetuin-A levels were associated with insulin resistance. However, the longitudinal association of fetuin-A with incident type 2 diabetes mellitus is unknown. OBJECTIVE: To determine whether fetuin-A levels are associated with incident diabetes in older persons. DESIGN, SETTING, AND PARTICIPANTS: Observational study among 3075 well-functioning persons aged 70 to 79 years. In this case-cohort study, we retrospectively measured fetuin-A levels in baseline serum among 406 randomly selected participants without prevalent diabetes, and all participants who developed incident diabetes mellitus during a 6-year follow-up (to August 31, 2005). MAIN OUTCOME MEASURE: Incident diabetes mellitus. RESULTS: Incident diabetes developed in 135 participants (10.1 cases/1000 person-years). Participants with fetuin-A levels within the highest tertile (> 0.97 g/L) had an increased risk of incident diabetes (13.3 cases/1000 person-years) compared with participants in the lowest tertile (< or = 0.76 g/L) (6.5 cases/1000 person-years) in models adjusted for age, sex, race, waist circumference, body weight, physical activity, blood pressure level, fasting glucose level, high-density lipoprotein cholesterol concentration, triglyceride concentration, and C-reactive protein level (adjusted hazard ratio, 2.41; 95% confidence interval, 1.28-4.53; P = .007). The association was not affected by adipocytokine levels but was moderately attenuated by adjustment for visceral adiposity (adjusted hazard ratio of highest vs lowest tertile 1.72; 95% confidence interval, 0.98-3.05; P = .06). CONCLUSION: Among well-functioning older persons, serum fetuin-A is associated with incident diabetes, independent of other markers of insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
(1998) · PubMed · Cited by 2,737
The Continuing Epidemics of Obesity and Diabetes in the United States
Mokdad, A. H. (2001) · JAMA · doi:10.1001/jama.286.10.1195 · Cited by 2,730
The Robust Inference for the Cox Proportional Hazards Model
Lin, D. Y., & Wei, L. J. (1989) · Journal of the American Statistical Association · doi:10.1080/01621459.1989.10478874 · Cited by 2,695
A case-cohort design for epidemiologic cohort studies and disease prevention trials
PRENTICE, R. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.1 · Cited by 1,439
Adiponectin and development of type 2 diabetes in the Pima Indian population
Lindsay, R. S., Funahashi, T., Hanson, R. L., Matsuzawa, Y., Tanaka, S., Tataranni, P. A., Knowler, W. C., & Krakoff, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09335-2 · Cited by 1,094
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Schäfer, C., Heiss, A., Schwarz, A., Westenfeld, R., Ketteler, M., Floege, J., Müller-Esterl, W., Schinke, T., & Jahnen-Dechent, W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17202 · Cited by 924
Greenland (2000) · doi:10.1161/01.cir.101.1.e16 · Cited by 924
Ketteler, M., Bongartz, P., Westenfeld, R., Wildberger, J. E., Mahnken, A. H., Böhm, R., Metzger, T., Wanner, C., Jahnen-Dechent, W., & Floege, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12710-9 · Cited by 910
Analysis of Case-Cohort Designs
Barlow, W. E., Ichikawa, L., Rosner, D., & Izumi, S. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00102-x · Cited by 682
Vionnet, N., Hani, E. H., Dupont, S., Gallina, S., Francke, S., Dotte, S., De Matos, F., Durand, E., Leprêtre, F., Lecoeur, C., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316887 · Cited by 680
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome
Kissebah, A. H., Sonnenberg, G. E., Myklebust, J., Goldstein, M., Broman, K., James, R. G., Marks, J. A., Krakower, G. R., Jacob, H. J., Weber, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14478 · Cited by 638
Declerck, P., Alessi, M., Verstreken, M., Kruithof, E., Juhan-Vague, I., & Collen, D. (1988) · Blood · doi:10.1182/blood.v71.1.220.220 · Cited by 537
Stefan, N., Hennige, A. M., Staiger, H., Machann, J., Schick, F., Kröber, S. M., Machicao, F., Fritsche, A., & Häring, H.-U. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1938 · Cited by 474
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study
Perseghin, G., Ghosh, S., Gerow, K., & Shulman, G. I. (1997) · Diabetes · doi:10.2337/diab.46.6.1001 · Cited by 367
Moe, S. M., Reslerova, M., Ketteler, M., O'Neill, K., Duan, D., Koczman, J., Westenfeld, R., Jahnen-Dechent, W., & Chen, N. X. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00333.x · Cited by 366
Improved Insulin Sensitivity and Resistance to Weight Gain in Mice Null for the Ahsg Gene
Mathews, S. T., Singh, G. P., Ranalletta, M., Cintron, V. J., Qiang, X., Goustin, A. S., Jen, K.-L. C., Charron, M. J., Jahnen-Dechent, W., & Grunberger, G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2450 · Cited by 342
Auberger, P., Falquerho, L., Contreres, J. O., Pages, G., Cam, G. L., Rossi, B., & Cam, A. L. (1989) · Cell · doi:10.1016/0092-8674(89)90098-6 · Cited by 321
Association Between Human Fetuin-A and the Metabolic Syndrome: Data From the Heart and Soul Study
Ix, J. H., Shlipak, M. G., Brandenburg, V. M., Ali, S., Ketteler, M., & Whooley, M. A. (2006) · Circulation · doi:10.1161/circulationaha.105.588723 · Cited by 316
Self-citationStenvinkel, P., Wang, K., Qureshi, A. R., Axelsson, J., Pecoits-Filho, R., Gao, P., Barany, P., Lindholm, B., Jogestrand, T., Heimberger, O., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00345.x · Cited by 312
McNeely, M. J., Boyko, E. J., Weigle, D. S., Shofer, J. B., Chessler, S. D., Leonnetti, D. L., & Fujimoto, W. Y. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.65 · Cited by 308
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology
Howard, B. V., Rodriguez, B. L., Bennett, P. H., Harris, M. I., Hamman, R., Kuller, L. H., Pearson, T. A., & Wylie-Rosett, J. (2002) · Circulation · doi:10.1161/01.cir.0000013953.41667.09 · Cited by 308
Lithell, H., & Zethelius, B. (1998) · Cited by 304
Srinivas, P. R. (1993) · Molecular Endocrinology · doi:10.1210/me.7.11.1445 · Cited by 243
Association of Serum Fetuin-A With Insulin Resistance in Type 2 Diabetic and Nondiabetic Subjects
Mori, K., Emoto, M., Yokoyama, H., Araki, T., Teramura, M., Koyama, H., Shoji, T., Inaba, M., & Nishizawa, Y. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1484 · Cited by 213
Association of serum fetuin-A levels with mortality in dialysis patients
Hermans, M. M. H., Brandenburg, V., Ketteler, M., Kooman, J. P., van der Sande, F. M., Boeschoten, E. W., Leunissen, K. M. L., Krediet, R. T., & Dekker, F. W. (2007) · Kidney International · doi:10.1038/sj.ki.5002178 · Cited by 189
Wahl, P. W., Savage, P. J., Psaty, B. M., Orchard, T. J., Robbins, J. A., & Tracy, R. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04055-0 · Cited by 178
Computing the Cox Model for Case Cohort Designs
Therneau, T. M., & Li, H. (1999) · Lifetime Data Analysis · doi:10.1023/a:1009691327335 · Cited by 164
Ix, J. H., Chertow, G. M., Shlipak, M. G., Brandenburg, V. M., Ketteler, M., & Whooley, M. A. (2007) · Circulation · doi:10.1161/circulationaha.106.682450 · Cited by 160
Self-citationRauth, G., Poeschke, O., Fink, E., Eulitz, M., Tippmer, S., Kellerer, M., Häring, H.-U., Nawratil, P., Haasemann, M., Jahnen‐Dechent, W., et al. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb16663.x · Cited by 143
Fetuin-null mice are protected against obesity and insulin resistance associated with aging
Mathews, S. T., Rakhade, S. N., Zhou, X., Parker, G. C., Coscina, D. V., & Grunberger, G. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.071 · Cited by 141
Westenfeld, R., Schäfer, C., Smeets, R., Brandenburg, V. M., Floege, J., Ketteler, M., & Jahnen‐Dechent, W. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm094 · Cited by 103
Marked acceleration of exogenous fatty acid incorporation into cellular triglycerides by fetuin.
Cayatte, A. J., Kumbla, L., & Subbiah, M. T. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39445-1 · Cited by 80
Ix, J. H., Chertow, G. M., Shlipak, M. G., Brandenburg, V. M., Ketteler, M., & Whooley, M. A. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl204 · Cited by 76
Self-citationBovine fetuin is an inhibitor of insulin receptor tyrosine kinase
Mathews, S. T., Srinivas, P. R., Leon, M. A., & Grunberger, G. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00737-6 · Cited by 68
Resnick, H. E., Shorr, R. I., Kuller, L. H., Franse, L. V., & Harris, T. B. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00359-6 · Cited by 63
Fetuin-A Is an Independent Predictor of Death after ST-Elevation Myocardial Infarction
Lim, P., Collet, J. P., Moutereau, S., Guigui, N., Mitchell-Heggs, L., Loric, S., Bernard, M., Benhamed, S., Montalescot, G., Dubois‐Randé, J., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.084947 · Cited by 56
Systemic and local levels of fetuin-A in calcific aortic valve stenosis
Kaden, J. J., Reinöhl, J., Blesch, B., Brueckmann, M., Haghi, D., Borggrefe, M. M., Schmitz, F., Klomfaß, S., Pillich, M., & Ortlepp, J. R. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.2.193 · Cited by 49
Fetuin-A is not associated with mortality in chronic kidney disease
Ix, J. H., Shlipak, M. G., Sarnak, M. J., Beck, G. J., Greene, T., Wang, X., Kusek, J. W., Collins, A. J., Levey, A. S., & Menon, V. (2007) · Kidney International · doi:10.1038/sj.ki.5002549 · Cited by 35
Self-citationCintrón, V. J., Ko, M. S. H., Chi, K. D., Gross, J. P., Srinivas, P. R., Goustin, A. S., & Grunberger, G. (2000) · Journal of Diabetes Research · doi:10.1155/edr.2000.249 · Cited by 17
Grunberger, G. (2010) · Taylor & Francis eBooks · doi:10.4324/9780203302958_chapter_15 · Cited by 5
Cited by
Schwenzer, N. F., Springer, F., Schraml, C., Stefan, N., Machann, J., & Schick, F. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.023 · Cited by 749
Bennett, J. M., Reeves, G., Billman, G. E., & Sturmberg, J. P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00316 · Cited by 531
Causes and Metabolic Consequences of Fatty Liver
Stefan, N., Kantartzis, K., & Häring, H.-U. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 532
The role of hepatokines in metabolism
Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500
The impact of insulin resistance on the kidney and vasculature
Artunc, F., Schleicher, E., Weigert, C., Fritsche, A., Stefan, N., & Häring, H.-U. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.145 · Cited by 462
Metadata
- Authors
- Ix, J. H.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-07-09
- Volume
- 300
- Issue
- 2
- Pages
- 182
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2089151518
- Cited by
- 267
- References
- 48
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.